The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including American Express Co. (AXP), Lockheed ...

UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...

In the latest quarter, 5 analysts provided ratings for ResMed RMD, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing how ...

(Image Credits: Pixabay) ResMed on Tuesday announced that it has launched AirSense 11 in India. According to the company’s statement, it is the next-generation Continuous Positive Airway ...

The Zacks analyst is impressed that the market success of ResMed's AirSense 10 and the AirSense 11 platforms fuel the global device sales. New patient activations and ReSupply boosts Masks growth.

CSL trades at a 12-month forward PE of ~28x, representing a discount to its 10-year average of ~31x ... are positive on sleep treatment company ResMed and think it could be an ASX 200 share ...